These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7667356)

  • 1. Stimulus properties of some analogues of 4-methylaminorex.
    Russell BR; Beresford RA; Schmierer DM; McNaughton N; Clark CR
    Pharmacol Biochem Behav; 1995; 51(2-3):375-8. PubMed ID: 7667356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulus properties of a new designer drug: 4-methylaminorex ("U4Euh").
    Glennon RA; Misenheimer B
    Pharmacol Biochem Behav; 1990 Mar; 35(3):517-21. PubMed ID: 1971111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex.
    Young R; Glennon RA
    Pharmacol Biochem Behav; 1993 May; 45(1):229-31. PubMed ID: 8516363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminorex produces stimulus effects similar to amphetamine and unlike those of fenfluramine.
    Young R
    Pharmacol Biochem Behav; 1992 May; 42(1):175-8. PubMed ID: 1356272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discrimination analysis of pseudoephedrine in rats.
    Tongjaroenbuangam W; Meksuriyen D; Govitrapong P; Kotchabhakdi N; Baldwin BA
    Pharmacol Biochem Behav; 1998 Feb; 59(2):505-10. PubMed ID: 9477001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavioral effects of the stereoisomers of 4-methylaminorex, a psychostimulant, in the rat.
    Batsche K; Ashby CR; Lee C; Schwartz J; Wang RY
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1029-39. PubMed ID: 7912274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influencing the specificity of drug mixture discriminations by varying the training procedure.
    Stolerman IP; Mariathasan EA; White JA
    Behav Pharmacol; 1999 Nov; 10(6-7):657-64. PubMed ID: 10780507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.
    Dukat M; Wesolowska A; Young R; Glennon RA
    Pharmacol Biochem Behav; 2007; 87(2):203-7. PubMed ID: 17540440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of (-)ephedrine.
    Young R; Glennon RA
    Pharmacol Biochem Behav; 1998 Jul; 60(3):771-5. PubMed ID: 9678664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse.
    Young R; Glennon RA
    Psychopharmacology (Berl); 1998 Dec; 140(3):250-6. PubMed ID: 9877004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discriminative stimulus properties of legal, over-the-counter stimulants administered singly and in binary and ternary combinations.
    Gauvin DV; Moore KR; Youngblood BD; Holloway FA
    Psychopharmacology (Berl); 1993; 110(3):309-19. PubMed ID: 7831424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine.
    Kueh D; Baker LE
    Psychopharmacology (Berl); 2007 Jan; 189(4):447-57. PubMed ID: 17019568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulus properties of nicotine, amphetamine, and chlordiazepoxide as positive features in a pavlovian appetitive discrimination task in rats.
    Palmatier MI; Wilkinson JL; Metschke DM; Bevins RA
    Neuropsychopharmacology; 2005 Apr; 30(4):731-41. PubMed ID: 15592350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological specificity of N-methyl-D-aspartate discrimination in rats.
    Grech DM; Willetts J; Balster RL
    Neuropharmacology; 1993 Apr; 32(4):349-54. PubMed ID: 8098862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of monoaminergic and neuropeptide systems to 4-methylaminorex: a new stimulant of abuse.
    Hanson GR; Bunker CF; Johnson M; Bush L; Gibb JW
    Eur J Pharmacol; 1992 Aug; 218(2-3):287-93. PubMed ID: 1358636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central stimulants as discriminative stimuli. Asymmetric generalization between (-)ephedrine and S(+)methamphetamine.
    Bondareva TS; Young R; Glennon RA
    Pharmacol Biochem Behav; 2002 Dec; 74(1):157-62. PubMed ID: 12376163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants.
    Baker LE; Miller ME; Svensson KA
    Behav Pharmacol; 1997 Jun; 8(2-3):243-52. PubMed ID: 9833019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of psychomotor stimulants in the cat.
    Kilbey MM; Ellinwood EH
    Psychopharmacology (Berl); 1979 May; 63(2):151-3. PubMed ID: 38476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical binding at dopamine and serotonin transporters contribute to the discriminative stimulus effects of mephedrone.
    DeLarge AF; Erwin LL; Winsauer PJ
    Neuropharmacology; 2017 Jun; 119():62-75. PubMed ID: 28396142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine.
    Mechanic JA; Wasielewski JA; Carl KL; Holloway FA
    Pharmacol Biochem Behav; 2002 Jul; 72(4):767-77. PubMed ID: 12062565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.